​

Lipocine (LPCN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Lipocine Revenue Highlights

Latest Revenue (Y)

$11.20M

Latest Revenue (Q)

$3.49M

Main Segment (Y)

Royalty

Lipocine Revenue by Period

Lipocine Revenue by Year

DateRevenueChange
2024-12-31$11.20M-492.80%
2023-12-31$-2.85M-670.16%
2022-12-31$500.00K-96.90%
2021-12-31$16.14M100.00%
2020-12-31--100.00%
2019-12-31$164.99K-61.45%
2018-12-31$428.03K100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--100.00%
2012-12-31$7.71M100.00%
2011-12-31--

Lipocine generated $11.20M in revenue during NA 2024, up -492.80% compared to the previous quarter, and up 6787.17% compared to the same period a year ago.

Lipocine Revenue by Quarter

DateRevenueChange
2024-12-31$3.49M100.00%
2024-09-30--100.00%
2024-06-30$89.56K-98.82%
2024-03-31$7.62M3423.40%
2023-12-31$216.19K-106.92%
2023-09-30$-3.12M100.00%
2023-06-30--100.00%
2023-03-31$54.99K100.00%
2022-12-31-100.00%
2022-09-30--100.00%
2022-06-30$500.00K100.00%
2022-03-31--100.00%
2021-12-31$16.09M29150.18%
2021-09-30$54.99K100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--100.00%
2019-09-30$164.99K100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--100.00%
2018-03-31$428.03K100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$13.50M100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31--

Lipocine generated $3.49M in revenue during Q4 2024, up 100.00% compared to the previous quarter, and up -111.83% compared to the same period a year ago.

Lipocine Revenue Breakdown

Lipocine Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Royalty$298.14K---
License-$109.99K$500.00K$11.00M
Sales-based royalties---$54.99K
Minimum guaranteed royalties---$4.05M
Materials---$1.04M

Lipocine's latest annual revenue breakdown by segment (product or service), as of Dec 24: Royalty (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 25
Reportable Segment$93.86K

Lipocine's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Reportable Segment (100.00%).

Lipocine Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AKBAAkebia Therapeutics$160.18M$46.50M
FBIOFortress Biotech$55.13M$13.14M
LPCNLipocine$11.20M$3.49M
DAREDaré Bioscience$9.78M$-63.65K
CRVOCervoMed--
RVPHReviva Pharmaceuticals--
RNAZTransCode Therapeutics--
RNTXRein Therapeutics--

LPCN Revenue FAQ

What is Lipocine’s yearly revenue?

Lipocine's yearly revenue for 2024 was $11.2M, representing a decrease of -492.80% compared to 2023. The company's yearly revenue for 2023 was $-2.851M, representing a decrease of -670.16% compared to 2022. LPCN's yearly revenue for 2022 was $500K, representing a decrease of -96.90% compared to 2021.

What is Lipocine’s quarterly revenue?

Lipocine's quarterly revenue for Q4 2024 was $3.49M, a 100.00% increase from the previous quarter (Q3 2024), and a 1514.99% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). LPCN's quarterly revenue for Q2 2024 was $89.56K, a -98.82% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Lipocine’s revenue growth rate?

Lipocine's revenue growth rate for the last 3 years (2022-2024) was 2139.63%, and for the last 5 years (2020-2024) was 0%.

What are Lipocine’s revenue streams?

Lipocine's revenue streams in c 24 are Royalty

What is Lipocine’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Lipocine was Royalty. This segment made a revenue of $298.14K, representing 100.00% of the company's total revenue.